Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement [0.03%]
MYC::IGH融合和BCL2重排的浆细胞样淋巴瘤
Mohammad Barouqa,Patricia Greipp,Rebecca King et al.
Mohammad Barouqa et al.
Maria A Pereda,Kelly Scarberry,Jignesh Dalal
Maria A Pereda
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens [0.03%]
EB病毒阴性布鲁顿淋巴瘤B细胞受体结合自身抗原的修饰异构体
Theresa Bock,Moritz Bewarder,Onur Cetin et al.
Theresa Bock et al.
Burkitt lymphoma (BL) represents the most aggressive B-cell-lymphoma. Beside the hallmark of IG-MYC-translocation, surface B-cell receptor (BCR) is expressed, and mutations in the BCR pathway are frequent. Coincidental infections in endemic...
CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment [0.03%]
与复发或达雷木单抗治疗后产生的CAR-T细胞相比，诊断时分离的多发性骨髓瘤患者的CAR-T细胞具有更好的细胞毒性功能
Audrey Abecassis,Nathalie Roders,Maxime Fayon et al.
Audrey Abecassis et al.
Chimeric antigen receptor T cells (CAR-T) have provided promising results in multiple myeloma (MM). However, many patients still relapse, pointing toward the need of improving this therapy. Here, we analyzed peripheral blood T cells from MM...
Radiologic zebra line sign in a patient with Langerhans cell histiocytosis on bisphosphonate therapy [0.03%]
朗格汉斯细胞组织细胞增生症患者使用双膦酸盐治疗的放射学斑马线征
Kenichi Sakamoto,Yoko Shioda
Kenichi Sakamoto
Autologous stem cell transplantation in a patient with scleromyxedema [0.03%]
一例硬红斑样毛细血管扩张性皮肤病（ scleromyxedema）患者的自体造血干细胞移植
Sunita Nathan,Celalettin Ustun
Sunita Nathan
Giant circulating malignant cells spotted in feathered edge of blood film [0.03%]
在血膜 fringe 区域发现巨大的恶性循环肿瘤细胞
Robert J Guo,Tyler W Smith
Robert J Guo
An artificial intelligence system applied to recurrent cytogenetic aberrations and genetic progression scores predicts MYC rearrangements in large B-cell lymphoma [0.03%]
一种人工智能系统应用于套细胞淋巴瘤反复出现的染色体异常和遗传进程评分可预测大B细胞淋巴瘤中的MYC重排
Rolando García,Anas Hussain,Weina Chen et al.
Rolando García et al.
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, is characterized by MYC rearrangements (MYC R) in up to 15% of cases, and these have unfavorable prognosis. Due to cryptic rearrangements and variations in...
Abdulaziz Altwijri,Nourah Faden,Mansour Alfayez
Abdulaziz Altwijri
Yingcai Huang,Haiyan Cui,Yanxia Chen et al.
Yingcai Huang et al.